Fasciola hepatica, also known as the liver fluke, is a trematode that infects livestock and humans causing fasciolosis, a zoonotic disease of increasing importance due to its worldwide distribution and high economic losses. This parasite immunoregulates the host immune system by inducing a strong Th2 and regulatory T immune response by immunomodulating dendritic cell (DC) maturation and alternative activation of macrophages. In this paper, we show that F. hepatica infection in mice induces the upregulation of heme-oxygenase-1 (HO-1), the rate-limiting enzyme in the catabolism of free heme that regulates the host inflammatory response. We show and characterize two different populations of antigen presenting cells that express HO-1 during infection in the peritoneum of infected animals. Cells that expressed high levels of HO-1 expressed intermediate levels of F4/80 but high expression of CD11c, CD38, TGFβ, and IL-10 suggesting that they correspond to regulatory DCs. On the other hand, cells expressing intermediate levels of HO-1 expressed high levels of F4/80, CD68, Ly6C, and FIZZ-1, indicating that they might correspond to alternatively activated macrophages. Furthermore, the pharmacological induction of HO-1 with the synthetic metalloporphyrin CoPP promoted F. hepatica infection increasing the clinical signs associated with the disease. In contrast, treatment with the HO-1 inhibitor SnPP protected mice from parasite infection, indicating that HO-1 plays an essential role during F. hepatica infection. Finally, HO-1 expression during F. hepatica infection was associated with TGFβ and IL-10 levels in liver and peritoneum, suggesting that HO-1 controls the expression of these immunoregulatory cytokines during infection favoring parasite survival in the host. These results contribute to the elucidation of the immunoregulatory mechanisms induced by F. hepatica in the host and provide alternative checkpoints to control fasciolosis.
Fasciola hepatica, also known as the liver fluke, is a trematode that infects livestock and humans causing fasciolosis, a zoonotic disease of increasing importance due to its worldwide distribution and high economic losses. This parasite immunoregulates the host immune system by inducing a strong Th2 and regulatory T immune response by immunomodulating dendritic cell (DC) maturation and alternative activation of macrophages. In this paper, we show that F. hepatica infection in mice induces the upregulation of heme-oxygenase-1 (HO-1), the rate-limiting enzyme in the catabolism of free heme that regulates the host inflammatory response. We show and characterize two different populations of antigen presenting cells that express HO-1 during infection in the peritoneum of infected animals. Cells that expressed high levels of HO-1 expressed intermediate levels of F4/80 but high expression of CD11c, CD38, TGFβ, and IL-10 suggesting that they correspond to regulatory DCs. On the other hand, cells expressing intermediate levels of HO-1 expressed high levels of F4/80, CD68, Ly6C, and FIZZ-1, indicating that they might correspond to alternatively activated macrophages. Furthermore, the pharmacological induction of HO-1 with the synthetic metalloporphyrin CoPP promoted F. hepatica infection increasing the clinical signs associated with the disease. In contrast, treatment with the HO-1 inhibitor SnPP protected mice from parasite infection, indicating that HO-1 plays an essential role during F. hepatica infection. Finally, HO-1 expression during F. hepatica infection was associated with TGFβ and IL-10 levels in liver and peritoneum, suggesting that HO-1 controls the expression of these immunoregulatory cytokines during infection favoring parasite survival in the host. These results contribute to the elucidation of the immunoregulatory mechanisms induced by F. hepatica in the host and provide alternative checkpoints to control fasciolosis.
Keywords: helminth, heme-oxigenase-1, immune regulation, dendritic cell, macrophage inTrODUcTiOn Fasciolosis, a helminth infection caused by Fasciola hepatica, is of paramount importance due to its wide spectrum of definitive hosts (1) and its worldwide distribution (2) affecting both livestock and human health. World Health Organization (WHO) estimates that at least 2.4 million people are infected in more than 70 countries worldwide, with several million at risk. Several studies have independently demonstrated that F. hepatica-derived molecules inhibit or decrease dendritic cell (DC) activation, which results in the induction of a tolerogenic phenotype (3) (4) (5) (6) (7) . Furthermore, we have demonstrated that DCs from mice infected with F. hepatica have a semi-mature phenotype that is characterized by low MHC II and CD40 expression, high secretion of the immunoregulatory cytokine IL-10, and the ability to differentiate and expand IL-10-producing CD4 T cells (8) . In addition, different groups have reported that F. hepatica-derived molecules also modulate macrophage activation, inducing the alternative activation of IL-10-producing macrophages (9, 10) and inhibiting the production of proinflammatory cytokines, such as IL-1β (11), IL-10 (12), Arg-1, PDL-1 (13) , and PDL-2 (14, 15) . Thus, it has been hypothesized that F. hepatica may modulate both macrophages and DC function and fate as a mean to control its pathogenesis and survival in the infected hosts.
Heme-oxygenase-1 (HO-1), the rate-limiting enzyme in the catabolism of free heme, is involved in many physiological and pathophysiological processes, by affording cytoprotection (16) and regulating the host inflammatory response. Indeed, HO-1 is a stress-responsive enzyme important for defense against oxidant-induced injury during inflammatory processes and is highly inducible by a variety of stimuli, such as LPS, cytokines, heat shock, heavy metals, oxidants, and its substrate heme. Several works confirm that HO-1 plays a role in different infectious diseases, and can have both beneficial and detrimental consequences for the host immunity against pathogens (17) . For instance, HO-1 is able to promote Plasmodium liver infection (18) , whereas it plays a favorable role in the host during cerebral malaria (19). On the other hand, HO-1 controls a variety of infections in mice, including Mycobacterium avium (20) , Listeria monocytogenes (21), Plasmodium falciparum (22) , Salmonella typhimurium (23) , Toxoplasma gondii (24) , and respiratory syncytial virus (25) .
Expression of HO-1 in monocyte-derived DC inhibits LPSinduced maturation and reactive oxygen species production (26) . In addition, HO-1 + DCs express the anti-inflammatory cytokine IL-10 resulting in the inhibition of alloreactive T-cell proliferation (26) . Also, IL-10-producing anti-inflammatory macrophages (M2) express HO-1 (27) . Thus, HO-1 has been proposed to be key mediator of the anti-inflammatory effects of macrophages and DCs.
In the present study, we demonstrate that during infection with the trematode F. hepatica, HO-1 is upregulated by immune cells expressing F4/80 in the peritoneal cavity and liver. We also show that the pharmacological induction of HO-1 with the synthetic metalloporphyrin CoPP promotes F. hepatica infection increasing the clinical signs associated with the disease, such as liver damage. Moreover, treatment with the HO-1 inhibitor SnPP protected from parasite infection. The increase of HO-1 during F. hepatica infection was associated with the increase of TGFβ and IL-10 in liver and peritoneal exudate cells (PECs). Interestingly, we identified two different F4/80 + cell populations that expressed HO-1. HO-1 hi F4/80 int cells were characterized by the expression of CD11c, CD38, TGFβ, and IL-10 suggesting that they correspond to regulatory DCs. On the other hand, HO-1 int F4/80 hi cells expressed high levels of CD68, Ly6C, and FIZZ-1 indicating that they might be alternatively activated macrophages. Our results contribute to the elucidation of immunoregulatory mechanisms induced by F. hepatica in the host and could provide alternative checkpoints to control fasciolosis.
MaTerials anD MeThODs ethics statement
Mouse experiments were carried out in accordance with strict guidelines from the National Committee on Animal Research (Comisión Nacional de Experimentación Animal, CNEA, National Law 18.611, Uruguay) according to the international statements on animal use in biomedical research from the Pan American Health Organization and WHO. The protocol was approved by the Uruguayan Committee on Animal Research. Cattle's livers were collected during the routine work of a local abattoir (Frigorífico Carrasco) in Montevideo (Uruguay).
Mice
Six-to eight-week-old female BALB/c mice were obtained from DILAVE Laboratories (Uruguay). Animals were kept in the animal house (URBE, Facultad de Medicina, UdelaR, Uruguay) with water and food supplied ad libitum. Mouse handling and experiments were carried out in accordance with strict guidelines from the National Committee on Animal Research (CNEA, Uruguay). All procedures involving animals were approved by the Universidad de la República's Committee on Animal Research (CHEA Protocol Number: 070153-000180-16).
infections and cell cultures BALB/c mice were orally infected with 10 F. hepatica metacercariae (Baldwin Aquatics, USA) per animal. After 1, 2, or 3 weeks post-infection (wpi) mice were bled and PECs, spleens, and livers were removed. In order to evaluate the severity of the infection, a disease severity score was developed ( Table 1) , which was applied in blinded experiments by two independent experimenters. Alanine aminotransferase (ALT) activity in sera was determined by using a commercial kit (Spinreact, Spain) according to the manufacturers' instructions. PECs from infected and non-infected mice were washed twice with PBS containing 2% FBS and 0.1% sodium azide. The following antibodies were used in these experiments anti-CD11c (N418), -I-A/I-E (2G9), CD40 (HM40-3), -F4/80 (BM8), -CD11b (M1/70), -CD172a (P84), -Ly6C (HK1.4), and -Siglec-F (E50-2440). Cells were then washed twice with PBS containing 2% FBS and 0.1% sodium azide and fixed with 1% formaldehyde. Cell populations were analyzed using a BD FACSCalibur (BD-Biosciences) or Cyan (Beckman Coulter). Expression of HO-1 (ab13248) and CD68 (FA-11) were analyzed by intracellular staining. Antibodies were obtained from Affymetrix (CA, USA), from BD-Biosciences (CA, USA), from Biolegend (CA, USA) or from Abcam. 
Quantitative real-time rT-Pcr
Total RNA was isolated by use of TRI-reagent (Sigma-Aldrich) from spleen, liver, PEC and purified F4/80 int and F4/80 hi cells from PEC. Samples were analyzed in an Eco real-time PCR System (Illumina) using Fast SYBR ® Green Master Mix (Applied Biosystems). The reactions were performed according to the following settings: 95°C for 5 min for initial activation, followed by 40 thermal cycles of 10 s at 95°C and 30 s at 60°C. All reactions were performed with at least five biological replicates.
Microscopy analyses
Livers from infected mice after 3 wpi or non-infected mice (control) were harvested, embedded in OCT, and snap frozen in nitrogen. Sections were cut at a thickness of 6 µm, fixed with cold acetone for 10 min and blocked with 5% BSA in 3% rat serum for 1 h at room temperature. Sections were then overnight incubated at 4°C with anti-HO-1 (ab13248) and -F4/80 (BM8), stained with DAPI and visualized in an epifluorencense microscope Olympus IX-81 and confocal microscope Leica TCS-SP5-II. The same procedure and the same antibody were used to evaluate HO-1 expression in bovine livers from naturally infected and non-infected cattle. In this case, livers were first examined by the veterinary inspector at the abattoir and determined to be infected by the presence of multiple parasites found in the bile ducts. Livers from non-infected animals were identified by absence of liver damage and flukes.
statistical analysis
Results were analyzed using GraphPad Prism software (GraphPad Software, San Diego, CA, USA). Normality distribution was evaluated using the D' Agostino-Pearson omnibus normality test followed by one-way ANOVA with Bonferroni Multiple
Comparison test or a student's T test was used. Results were considered to be significantly different when p < 0.05 (*), 0.01 (**), or 0.001 (***).
resUlTs hO-1 expression is induced in F. hepaticainfected animals
We first evaluated whether HO-1 was expressed in F. hepaticainfected animals. To this end, mice were infected with 10 metacercariae and after 3 wpi, livers, spleens, and PECs were removed and HO-1 expression was analyzed by qRT-PCR, microscopy, and flow cytometry. Livers from infected mice expressed high levels of HO-1, both at the mRNA ( Figure 1A ) and protein levels ( Figure 1B) . Indeed, a 25-fold increase in the transcript levels was determined by qRT-PCR with respect to non-infected animals ( Figure 1A ). HO-1 expression was found both in the leukocyte infiltrates and the liver parenchyma ( Figure 1B) , while undetectable levels of HO-1 were found in control livers from naive mice ( Figure 1B) . HO-1 gene expression was also induced in PECs, revealing, similar to liver, a 25-fold increased in PECs from infected animals, comparing to control mice ( Figure 1C) . Moreover, HO-1 + cells were detected in the peritoneum both by flow cytometry and microscopy ( Figures 1D-F) . On the contrary, we failed to detect an increase in HO-1 transcript levels and protein expression by flow cytometry in spleens from infected-with respect to control animals ( Figure S1 in Supplementary Material).
The gene expression of HO-1 was also investigated in bovine livers (Figure 2 ) revealing an increase of HO-1 mRNA levels in livers from infected bovine with respect to non-infected animals ( Figure 2A ). This increase in HO-1 gene expression was confirmed at the protein level by microscopy ( Figure 2B ). HO-1 was expressed both in the hepatocytes (larger cells) and the infiltrated leukocytes (smaller cells) in livers from infected mice ( Figure 2B ). Altogether, these results indicate that HO-1 expression increases both in liver and PEC, but not in spleen, of F. hepatica-infected animals.
The Pharmacological inhibition or induction of hO-1 affects clinical signs associated to F. hepatica infection
The use of pharmacological agents and genetic probes to manipulate HO-1 has been widely used as a tool to explore the role of HO-1 in infections and other pathological systems, as well as its immune regulatory properties. Thus, we investigated whether the pharmacological induction or inhibition of HO-1, using cobalt (CoPP) and tin (SnPP) protoporphyrin IX, respectively, increased or ameliorated the clinical signs associated with by F. hepatica infection. The treatment consisted of five i.p. administrations of CoPP or SnPP at days −2, 2, 5, 12, and 17, with infection at day 0 ( Figure 3A) . Importantly, CoPP administration lead to a significant increase of HO-1 transcript levels, while SnPP administration did not change the HO-1 gene expression ( Figures S2A,B in Supplementary Material) Clinical signs were determined by two different read outs: (i) hepatic damage followed by ALT activity in serum, a common marker to detect hepatic dysfunction (30) , and (ii) general state of the animal by a defined clinical score (Figure 3) . The clinical score was defined according the parameters described in Table 1 . First, we evaluated the HO-1 transcript levels in livers and PECs from treated mice at 2 wpi, time were the highest differences in HO-1 expression were determined. Infected mice expressed high transcript levels of HO-1, both in liver ( Figure 3B ) and PEC ( Figure 3C) . Furthermore, when infected mice were treated with CoPP, they presented higher HO-1 transcript levels than infected mice in both biological samples, while SnPP-treatment dramatically reduced the gene expression of HO-1 in infected mice, both in liver ( Figure 3B ) and PEC ( Figure 3C ). Of note, when infected mice were treated with simultaneous administration of CoPP and SnPP, the HO-1 transcript levels both in PEC and liver were similar to those found for infected control mice (Figures 3B,C) .
Importantly, the expression of HO-1 correlated with the ALT activity levels found in sera. Indeed, CoPP-treated infected mice presented higher ALT activity levels in serum at 2 and 3 wpi ( Figure 3D) . On the contrary, SnPP-treated infected mice, had a remarkable decrease in ALT activity levels at 3 wpi with levels comparable to those of non-infected mice, although they were slightly increased ( Figure 3D) . The hepatic damage determined as ALT activity in serum found in CoPP-treated infected mice correlated with other clinical signs, such as hemorrhage, splenomegaly and increase in ascites and cells in the peritoneum (Figure 3E) . In contrast, SnPP-treated infected mice, presented a decreased clinical score as compared to controls. Importantly, control infected mice treated with a mix of SnPP and CoPP, presented the same clinical score as infected mice not treated with protoporfirins ( Figure 3E) . Importantly, non-infected mice treated with CoPP did not show either liver damage, changes in ALT activity in sera nor any clinical symptom related to the infection with respect to non-treated mice ( Figure S2C ,D in Supplementary Material). These results suggest that an increase of HO-1 expression augments the susceptibility of F. hepatica infection, while a decrease in this enzyme provides mice resistance to the infection.
It has been reported that HO-1 regulates the expression of multiple cytokines, and has essentially anti-inflammatory properties (26, (31) (32) (33) (34) . In order to further study the immune response induced in the group of mice treated with protoporphyrins, we evaluated the transcript levels of a panel of Th2/regulatory molecules that are highly expressed during F hepatica infection: FIZZ-1, IL-4, IL-10, and TGFβ. Indeed, at 2 wpi, livers from infected mice expressed high transcript levels of IL-10, TGFβ and FIZZ-1 ( Figure 4A) . Interestingly, IL-10 and TGFβ transcript levels were even higher in CoPP-treated infected mice, than control infected mice ( Figure 4B) . Moreover, SnPP-treated infected mice presented lower mRNA levels of IL-10 and FIZZ-1 than infected control mice ( Figure 4B) . Consistent with these results, simultaneous treatment with CoPP and SnPP did not induce any change in the mRNA levels of these molecules with respect to control infected mice ( Figure 4B) . Of note, IL-4 gene expression in liver was not modified either with F. hepatica infection nor the treatment with metal protoporphyrins.
Cells from the peritoneum of infected mice, on the other hand, expressed higher transcript levels of TGFβ, IL-4 and FIZZ-1 ( Figure 5A ), but not IL-10 as shown in liver. Surprisingly, PEC from CoPP-or SnPP-treated mice did not present any change in the expression of either TGFβ, IL-4, FIZZ-1 or IL-10, except for FIZZ-1 which was slightly decreased in SnPP-treated infected mice (Figure 5B) , consistent with lower hepatic damage and clinical score.
In summary, these results show that the induction of HO-1 is associated with higher levels of the immunoregulatory molecules IL-10 and TGFβ and the reparatory molecule FIZZ-1 in liver, while the inhibition of HO-1correlated with lower , SnPP (n = 7), SnPP/CoPP (n = 7), or PBS (n = 7). Asterisks indicate statistically significant differences (*p < 0.05, **p < 0.01, ***p < 0.001). Figure 6A) . Interestingly, although the F4/80 hi cell population was also detected in PECs from control mice (Figure 6A) , the expression of HO-1 was induced upon infection ( Figure 6B) . On the contrary, the HO-1 hi F4/80 int cell , SnPP (n = 7), SnPP/CoPP (n = 7), or PBS (n = 7). Asterisks indicate statistically significant differences (*p < 0.05, **p < 0.01). population was absent in control mice ( Figure 6A ) and expressed higher HO-1 levels than HO-1 int F4/80 hi cells from infected mice ( Figure 6B ). Of note, the F4/80 low population identified in infected mice were Siglec-F + (could correspond to eosinophils) and did not express HO-1 as determined by the corresponding isotype staining ( Figure S3 in Supplementary Material).
The presence of F4/80 + cells in PECs expressing different levels of this surface marker was also confirmed by microscopy, revealing co-localization with HO-1 ( Figure 7A) . Furthermore, F4/80 + HO-1 + cells were also identified in the leukocyte infiltrate present in livers from infected mice (Figure 7B ), while these cells were undetected in control livers (data not shown). HO-1 was also expressed by F4/80 -hepatocytes ( Figure 7B ) as mentioned earlier ( Figure 1B) In order to further characterize HO-1 + cells, we evaluated both populations and HO-1 expression during the process of infection. To this end, PECs and livers were collected at 1, 2, and 3 wpi. Interestingly HO-1 transcript levels augmented progressively with the course of infection ( Figure 8A) . PECs from infected and control mice were labeled and analyzed by expressed very low levels of Siglec-F (Figure 9) . Interestingly, the phenotype described for HO-1 int F4/80 hi cells resembled to that of peritoneal macrophages from naïve mice ( Figure S4 
DiscUssiOn
In this work, we show that HO-1 is a key immunoregulatory molecule during F. hepatica infection and that promotes infection and liver damage. The role of HO-1 in infections by intracellular pathogens has been previously approached, demonstrating an upregulation of HO-1 mRNA and/or protein expression in response to viral (25) , bacterial (23, (41) (42) (43) (44) (45) (46) , or protozoan parasitic (18, 19, 47) infections. Furthermore, overexpression or induction of HO-1 promotes persistence of other infectious agents, such as Leishmania chagasi and Plasmodium liver infection (18, 47) . However, to our knowledge, this is the first report demonstrating the role of HO-1 in favoring a helminth infection. The involvement of HO-1 in the anti-inflammatory immune response in F. hepatica-infected mice was confirmed using pharmacological approaches. We show that the pharmacological induction of HO-1 promoted clinical signs associated with F. hepatica infection, and it was correlated with an increase of IL-10 and TGFβ in liver, indicating that the induction of HO-1 is associated with the upregulation of these two immunoregulatory cytokines. The fact that the use of the enzymatic inhibitor of HO-1 SnPP significantly decreased the levels of IL-10, TGFβ, and FIZZ-1 in liver, even to lower levels to control infected mice (for IL-10 and FIZZ-1) strongly suggests that HO-1 is involved in the upregulation of IL-10, promoting parasite survival, and hence liver damage that leads to the upregulation of FIZZ-1 indicating liver fibrosis. Indeed, several studies have demonstrated that HO-1 mediates the anti-inflammatory effect of IL-10 (37, 48) showing that the use of competitive inhibitors or the knock down expression of HO-1 abrogated the suppressive effect of IL-10. In our model, this hypothesis is in agreement with the results obtained with the simultaneous administration of CoPP and SnPP, obtaining similar clinical signs and IL-10, TGFβ, and FIZZ-1 levels as non-treated mice. Further studies are needed to define which of the heme degradation products following the action of HO-1 activity iron, biliverdin, or CO, are responsible for these actions, as has been previously reported for other pathogens (23) . Alternatively, cytokine induction may be due to direct interaction of HO-1 with other host molecules. Interestingly, HO-1 gene expression is regulated at the transcriptional level, by several transcriptional factors including activator protein-1 (49, 50) , nuclear factor erythroid 2-related factor-2 (NRF2), nuclear factor-kappa B (50, 51), among others. Also, HO-1 expression is regulated by signaling cascades such as mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt (49, 52 ). In our model, the identification of the molecular mechanisms that lead to HO-1 upregulation in F. hepatica-infected animals will eventually contribute to the development of molecular strategies to control the infection.
Apart from its immunoregulatory properties, HO-1 also plays a significant role in inhibiting oxidant-induced injury during inflammatory processes (53) . In fact, an appropriate balance of the inflammatory and redox states is essential to resolve most infections and finally the infectious process (17) . In this context, another possibility is that F. hepatica induces HO-1 expression not only to evade the host immune response, but also to inhibit oxidant production by macrophages or other cells. One immunologically relevant place in the host for F. hepatica, is the peritoneal cavity, where the production of oxygen or nitrogen derived molecules could limit and restrain juvenile parasites. Indeed, lower levels of liver damage have been suggested to be the consequence of effective killing of the invading parasites within the peritoneum or shortly after reaching the liver (54) . In this context, F. hepatica-mediated HO-1 induction might support parasite survival, for instance by favoring its passage through the peritoneum to the liver.
Our data indicate that in the peritoneal cavity two different populations of antigen presenting cells express HO-1. Judged by the high expression of CD11c, CD38, MHCII and the immunoregulatory cytokines IL-10 and TGFβ, HO-1 hi F4/80 int cells could constitute tolerogenic myeloid-derived DCs (55) or regulatory DCs that potentially participate in the induction of specific regulatory or anergic T cells (8, 56) . Indeed, DCs conditioned with parasite-derived molecules can induce T cell anergy (8, 14, 56, 57) . It remains to be determined whether HO-1-expressing DCs can induce specific anergic or regulatory T cells in a HO-1 dependent mechanism. In contrast, HO-1 int F4/80 hi cells were characterized by the high expression of CD68, CD172a, Ly6C, CD11b, and FIZZ-1, as well as low levels of MHCII expression, indicating that they may correspond to alternatively activated macrophages (58) . In this line, the alternative activation of macrophages by F. hepatica or its derived molecules has been previously described (10, 39, 59, 60) . Macrophages play a central role in innate immune responses toward both extracellular and intracellular pathogens, particularly through the formation of reactive oxygen/nitrogen species (RO/NS) (61, 62) . Indeed, oxidative stress can kill F. hepatica flukes by a mechanism that may involve oxidation of proteins or lipids from parasite tegument since peroxyntrite or superoxide radicals significantly diminished parasite viability in vitro (54, 63) . Moreover, RO/NS can effectively target extracellular pathogens through the formation of extracellular traps (61) . Taking into account that HO-1 in macrophages limits the production of reactive species (34) and induces IL-10 producing anti-inflammatory macrophages (64) and that F. hepatica favors the alternative activation of macrophages (65, 66) , it is likely that HO-1 + macrophages at early stages allow F. hepatica survival in the peritoneum through ineffective free radical production.
Finally, the role of HO-1 in favoring F. hepatica infection in the natural host (e.g., livestock, human) remains unknown. Although we show preliminary data demonstrating an increase in HO-1 expression in livers from naturally infected cattle, further studies are necessary to determine whether HO-1 expression correlates with a certain stage of the infection or if participates in the immunoregulatory or anti-oxidant mechanisms during the infection in these hosts.
In conclusion, HO-1 overexpression benefits F. hepatica infection increasing clinical signs and liver damage. Upregulation of HO-1 leads to an increase of IL-10 which could promote and benefit parasite transport from the peritoneum to the liver. On the other hand, an enzymatic inhibitor of HO-1 provided mice HO-1) , TGFβ, IL-10, FIZZ-1, Arg-1, and CD38 was evaluated by qRT-PCR. Gene expression relative to GAPDH transcript levels is shown. Mice were analyzed individually: control mice n = 5 and F. hepatica-infected mice n = 5. Asterisks indicate statistically significant differences (*p < 0.05, **p < 0.01). 
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